Popis: |
PDF file - 127K, Supplementary Table S1: Details of breast cancer patients employed for this study. IDC (NOS), Invasive Ductal Carcinoma (Not Otherwise Specified); DCIS, Ductal Carcinoma In-Situ; ILC, Invasive lobular carcinoma; LN, lymph node status; na, not available; nd, not detected. Supplementary Table S2: Complete list of significant microRNAs identified from breast cancer tumour and serum samples. Supplementary Table S3: Complete list of significant breast cancer tumour microRNAs associated with clinicopathological features. Supplementary Table S4: Complete list of significant serum microRNAs associated with clinicopathological features. |